よむ、つかう、まなぶ。
07 参考資料 1－1 百日せきファクトシート［6.8MB］ (43 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_34803.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会 ワクチン評価に関する小委員会（第20回 8／29）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
する研究」
：百日咳小児入院例の後方視的調査（研究代表者 岡田賢司、研究分担者
菅
秀）. 2016.
88. 世 界 保 健 機 関 (WHO).
Disease
incidence
(Update
of
2014/December/02).
http://www.who.int/immunization/monitoring_surveillance/data/en/
89. MacNeil A, Dietz V and Cherian T. Vaccine preventable diseases: time to re-examine
global surveillance data? Vaccine 2014. 32: 2315-20.
90. Center for Disease Control and Prevention. Chapter 15: Pertussis. Epidemiology and
Prevention of Vaccine-Preventable Diseases The Pink Book: Course Textbook - 12th
Edition .2012. 215-32.
91. Center for Disease Control and Prevention. Recommended Childhood and Adolescent
Immunization Schedule-United States, 2006. MMWR. 2006.54:Q1-4
92. Cherry JD. The Epidemiology of Pertussis: A Comparison of the Epidemiology of the
disease Pertussis with the Epidemiology of Bordetella pertussis Infection. Pediatrics.
2005. 115; 1422-7.
93. Wirsing von König CH, Halperin, S, Riffelmann, M, and Guiso, N. Pertussis of adults and
infants. Lancet Infect Dis. 2002. 2:744-50.
94. Center for Disease Control and Prevention. Preventing Tetanus, Diphtheria, and Pertussis
Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular
Pertussis Vaccines. 2006. 55(RR03): 1-34.
95. Center for Disease Control and Prevention. Updated Tdap Vaccine Recommendations from
the ACIP, 2010. MMWR. 2011. 60: #01
96. Winter K, Harriman K, Zipprich J, Schechter R, Talarico J, Watt J, Chavez G. California
pertussis epidemic, 2010. J Pediatr 2012. 161: 1091-6.
97. Clark TA. Changing pertussis epidemiology: everything old is new again. J Infect Dis.
2014. 209: 978-81.
98. Chas DeBolt, Azadeh Tasslimi, Janna Bardi, Brandon Troy Leader, Brian Hiatt, Xuan Qin,
Manisha Patel, Stacey Martin, Maria Lucia Tondella, Pam Cassiday, Amanda Faulkner,
Nancy E. Messonnier, Thomas A. Clark, Sarah Meyer. Pertussis Epidemic — Washington,
2012. MMWR Weekly. 2012. 61:517-22.
99. Acosta AM, DeBolt C, Tasslimi A, Lewis M, Stewart LK, Misegades LK, Messonnier
NE, Clark TA, Martin SW, Patel M. Tdap vaccine effectiveness in adolescents during the
2012 Washington State pertussis epidemic. Pediatrics. 2015. 135 :981-9.
100. Center for Disease Control and Prevention. Pertussis epidemic--Washington, 2012.
MMWR Morb Mortal Wkly Rep 2012. 61: 517-22.
101. Kamiya H, Cho BH, Messonnier ML, Clark TA, Liang JL. Impact and cost-effectiveness of
a second tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine
42
：百日咳小児入院例の後方視的調査（研究代表者 岡田賢司、研究分担者
菅
秀）. 2016.
88. 世 界 保 健 機 関 (WHO).
Disease
incidence
(Update
of
2014/December/02).
http://www.who.int/immunization/monitoring_surveillance/data/en/
89. MacNeil A, Dietz V and Cherian T. Vaccine preventable diseases: time to re-examine
global surveillance data? Vaccine 2014. 32: 2315-20.
90. Center for Disease Control and Prevention. Chapter 15: Pertussis. Epidemiology and
Prevention of Vaccine-Preventable Diseases The Pink Book: Course Textbook - 12th
Edition .2012. 215-32.
91. Center for Disease Control and Prevention. Recommended Childhood and Adolescent
Immunization Schedule-United States, 2006. MMWR. 2006.54:Q1-4
92. Cherry JD. The Epidemiology of Pertussis: A Comparison of the Epidemiology of the
disease Pertussis with the Epidemiology of Bordetella pertussis Infection. Pediatrics.
2005. 115; 1422-7.
93. Wirsing von König CH, Halperin, S, Riffelmann, M, and Guiso, N. Pertussis of adults and
infants. Lancet Infect Dis. 2002. 2:744-50.
94. Center for Disease Control and Prevention. Preventing Tetanus, Diphtheria, and Pertussis
Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular
Pertussis Vaccines. 2006. 55(RR03): 1-34.
95. Center for Disease Control and Prevention. Updated Tdap Vaccine Recommendations from
the ACIP, 2010. MMWR. 2011. 60: #01
96. Winter K, Harriman K, Zipprich J, Schechter R, Talarico J, Watt J, Chavez G. California
pertussis epidemic, 2010. J Pediatr 2012. 161: 1091-6.
97. Clark TA. Changing pertussis epidemiology: everything old is new again. J Infect Dis.
2014. 209: 978-81.
98. Chas DeBolt, Azadeh Tasslimi, Janna Bardi, Brandon Troy Leader, Brian Hiatt, Xuan Qin,
Manisha Patel, Stacey Martin, Maria Lucia Tondella, Pam Cassiday, Amanda Faulkner,
Nancy E. Messonnier, Thomas A. Clark, Sarah Meyer. Pertussis Epidemic — Washington,
2012. MMWR Weekly. 2012. 61:517-22.
99. Acosta AM, DeBolt C, Tasslimi A, Lewis M, Stewart LK, Misegades LK, Messonnier
NE, Clark TA, Martin SW, Patel M. Tdap vaccine effectiveness in adolescents during the
2012 Washington State pertussis epidemic. Pediatrics. 2015. 135 :981-9.
100. Center for Disease Control and Prevention. Pertussis epidemic--Washington, 2012.
MMWR Morb Mortal Wkly Rep 2012. 61: 517-22.
101. Kamiya H, Cho BH, Messonnier ML, Clark TA, Liang JL. Impact and cost-effectiveness of
a second tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine
42